NCT06928922 2026-01-13
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
Clinical Trials
7 trialsNCT07261098 2025-12-03
The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension
Shanghai Chest Hospital
Phase 2 Not yet recruiting
NCT05664971 2025-12-02
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Completed
NCT05000684 2025-02-20
Study of JS004 Combined With Toripalimab for Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Completed
NCT06106152 2024-03-26
WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT03330834 2020-07-13
CAR-T Cell Immunotherapy for Advanced Lung Cancer
Sun Yat-sen University
Phase 1 Terminated
NCT02801734 2018-03-29
EQUIP
National Cancer Centre, Singapore
Phase NA Completed